Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Stage-specific risk factors of cardiometabolic multimorbidity: A systematic review and meta-analysis from incidence
Lin Yang1, Zirui Zhang1, Jie Zhang1
1Department of Epidemiology and Health Statistics, School of Public Health and Nursing, Hangzhou Normal University, Hangzhou, China.
Background:
Cardiometabolic multimorbidity (CMM)-the co-occurrence of diabetes, cardiovascular disease, and related conditions-is a growing global health burden. Identifying risk factors across its developmental trajectory is critical for targeted prevention.
Methods:
We conducted a systematic review and meta-analysis to quantify risk factors for the incidence and progression of CMM across five transitions: health → first cardiometabolic disease (FCMD), FCMD→CMM, CMM→death, FCMD→death, and health→death. For incidence, we used conventional random-effects meta-analysis to estimate pooled odds ratios (ORs). For disease progression, we applied Bayesian multi-state meta-analysis to estimate pooled hazard ratios (HRs). Subgroup analyses were performed to assess heterogeneity.
Results:
Nine modifiable risk factors were identified for CMM incidence. Metabolic factors (overweight: OR=1.82, obesity: OR=3.13, hypertension: OR=2.05) and socioeconomic determinants (low income: OR=1.24, living alone: OR=1.58) showed the strongest associations. Depression (OR=1.70) and behavioral factors (smoking, physical inactivity, alcohol use) further increased risk. Trajectory analyses revealed stage-specific drivers: overweight/obesity drove transitions from healthy to FCMD (OR=1.69) and FCMD to CMM (OR=1.36), while smoking showed escalating effects across stages (health→FCMD: OR=1.22; FCMD→CMM: OR=1.37; CMM→death: OR=1.83). Alcohol use and physical inactivity increased mortality risk (13-28 %). Heterogeneity primarily stemmed from outcome measurement methods (i.e., objective vs. self-reported) and CMM composition.
Conclusion:
CMM prevention requires stage-specific prioritization: early weight management, hypertension control and depression intervention to mitigate incidence; smoking cessation to curb progression; and intensified lifestyle interventions targeting smoking and alcohol cessation in established CMM. This evidence underscores the need for dynamic, trajectory-informed interventions to reduce the CMM burden.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
Related Concept Videos
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Heart Failure I: Introduction